TI
ALXN

TT International’s Alexion Pharmaceuticals ALXN Stock Holding History

TT International’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-25,625
Closed -$3.46M – 58
2019
Q1 		$3.46M Sell
25,625
-7,788
-23% -$968K 0.37% 31
2018
Q4 		$3.23M Sell
33,413
-21,103
-39% -$2.49M 0.42% 29
2018
Q3 		$7.58M Sell
54,516
-627
-1% -$78.7K 0.85% 26
2018
Q2 		$6.85M Sell
55,143
-2,645
-5% -$309K 1.11% 23
2018
Q1 		$6.44K Buy
57,788
+8,709
+18% +$1.04M 0.28% 31
2017
Q4 		$5.87M Buy
+49,079
New +$5.98M 0.85% 29

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

TT International's ALXN Position: Q2 2019 in Review

TT International sold out of Alexion Pharmaceuticals (ALXN) in Q2 2019, closing a stake of 25,625 shares — an estimated $3.46M sold.

TT International first reported a position in ALXN in Q4 2017 and held it in 6 quarters. The position peaked at $7.58M in Q3 2018. 636 funds tracked by Wall St. Rank hold ALXN as of Q2 2019.

  • TT International reported no remaining Alexion Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • TT International sold 25,625 Alexion Pharmaceuticals shares in Q2 2019, an estimated $3.46M.
  • TT International first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 6 quarters.
  • TT International's Alexion Pharmaceuticals position peaked at $7.58M in Q3 2018.
  • 636 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2019.

Based on TT International's 13F filing for Q2 2019, filed 12 Aug 2019.